Abstract G q/11 protein-coupled human histamine H 1 receptors in Chinese hamster ovary cells stimulated with histamine undergo clathrin-dependent endocytosis followed by proteasome/lysosome-mediated down-regulation. In this study, we evaluated the effects of a sustained increase in intracellular Ca 
G protein-coupled receptors (GPCRs), which possess seven transmembrane domains, form the largest plasma membrane receptor family and play crucial roles in the regulation of cellular responses (Lefkowitz 2007) . When stimulated with agonists, GPCRs undergo G protein-coupled receptor kinase/ arrestin-mediated internalization (endocytosis) and subsequent down-regulation for cellular homeostasis (Reiter and Lefkowitz 2006; Tian et al. 2014; Gurevich and Gurevich 2015; Smith and Rajagopal 2016) : the internalization of receptors, that is, moving from the cell surface via the formation of endosomes into an intracellular compartment inaccessible to hydrophilic extracellular ligands, involves clathrin-or caveolae/lipid raft-mediated endocytosis (Mundell et al. 2006; Puthenveedu and von Zastrow 2006; Lajoie and Nabi 2007; Wolfe and Trejo 2007; Gong et al. 2008; Hanyaloglu and von Zastrow 2008) . The down-regulation of receptors, which is assessed by the loss of cellular binding sites for cell-penetrating hydrophobic ligands, generally involves the degradation of receptors via lysosomes or proteasomes (Shenoy 2007; Marchese et al. 2008; Cottrell 2013) . The ubiquitination of receptors is known to be involved in their internalization and down-regulation processes (Shenoy 2007; Marchese and Trejo 2013; Kennedy and Marchese 2015) .
Histamine H 1 receptors are G q/11 protein-coupled and Ca 2+ -mobilizing receptors, exist throughout the human body, and play roles in allergy and inflammation in peripheral tissues and arousal in the central nervous system (Hill 1990; Bakker et al. 2002; Monczor and Fernandez 2016) . We have been investigating the regulatory mechanisms of human histamine H 1 receptors, particularly those responsible for the agonist-induced internalization and down-regulation of H 1 receptors, since we demonstrated the first evidence for histamine-induced internalization of H 1 receptors in human astrocytoma cells (Hishinuma and Young 1995) . We previously reported that the agonist-induced internalization of H 1 receptors was transiently inhibited by Ca 2+ /calmodulin (Hishinuma et al. 1998) , during which the affinity of agonists for cell-surface H 1 receptors was dually regulated by Ca 2+ /calmodulin-dependent protein kinase II and protein phosphatase 2B (calcineurin) in human astrocytoma cells (Hishinuma and Ogura 2000) . Furthermore, we found that cell-surface H 1 receptors internalize in Chinese hamster ovary (CHO) cells stimulated with agonists via clathrindependent, but caveolae/lipid raft-independent endocytosis, which is a pre-requisite process for the subsequent downregulation of H 1 receptors via the prompt and protein kinase C/ubiquitin/proteasome-dependent degradation pathway as well as the slow and lysosome-dependent degradation pathway (Hishinuma et al. 2010) . Thus, the agonist-induced internalization and down-regulation of H 1 receptors appear to be tightly regulated by intracellular Ca 2+ signaling activated by H 1 receptors. Since agonist-induced increases in intracellular Ca 2+ concentrations were transient (Hishinuma and Ogura 2000) , we were prompted to examine how the internalization and down-regulation of H 1 receptors may be modulated by a sustained increase in intracellular Ca 2+ concentrations. Ionomycin, a Ca 2+ ionophore, promptly equilibrates intracellular and extracellular Ca 2+ , so that ionomycin induces rapid and sustained changes in intracellular Ca 2+ concentrations up to concentrations equivalent to extracellular Ca 2+ (Sato et al. 1988) . We herein present our novel results showing that ionomycin induced the Ca 2+ -dependent down-regulation of H 1 receptors without the apparent internalization of H 1 receptors and their lysosomal/ proteasomal degradation. H]mepyramine and myo-[ 3 H]inositol were purchased from PerkinElmer (Waltham, MA, USA). UBEI-41 was from BioGenova (Frederick, MD, USA) and fura 2-AM was from Wako Pure Chemicals Industries (Osaka, Japan). Primary antibodies [mouse anti-hemagglutinin (HA), RRID: AB_10064068] were purchased from Covance (Tokyo, Japan) and secondary antibodies (Alexa-Fluor-488-conjugated anti-mouse goat IgG, RRID: AB_25340695) were from Invitrogen (Tokyo, Japan). CHO-K1 cells (RCB0285, RRID: CVCL_0214) were from the RIKEN Bioresource Center (Tsukuba, Ibaraki, Japan) and human U373 MG astrocytoma cells (08061901, RRID: CVCL_2818) were from National Culture Collection (Porton Down, UK). AG 1-X8 anionexchange resin (100-200 mesh, formate form) was from Biorad (Tokyo, Japan). Other materials were from Sigma-Aldrich (Tokyo, Japan). Pirdonium was a generous gift from Dr. J.M. Young (Department of Pharmacology, University of Cambridge) and Prof. H. Timmerman (Department of Pharmacochemistry, Free University of Amsterdam).
Methods

Materials
Preparation of cells
Experimental protocols of this research were approved by the Institutional Safety Committee for Recombinant DNA Experiments, Meiji Pharmaceutical University (No. 1209). The study was not preregistered and neither randomization nor blinding was performed. CHO cells stably expressing transfected human histamine H 1 receptors or human U373 MG astrocytoma cells natively expressing histamine H 1 receptors were cultured in 150-cm 2 culture flasks, as described previously (Hishinuma et al. 2010 (Hishinuma et al. , 2012 (Hishinuma et al. 2014 ). The cell suspension or the membrane preparation was filtered through Whatman GF/B glass fiber filters (pre-soaked for at least 3 h in 0.3% polyethylenimine), using a 24-place cell harvester (Brandel, Gaithersburg, MD, USA). The filters were transferred to scintillation vial inserts and a 3-mL scintillator was added before the assessment of tritium by scintillation counting. All measurements were performed in quadruplicate.
Detection of histamine H 1 receptors using confocal immunofluorescence microscopy CHO cells stably expressing human histamine H 1 receptors tagged with three molecules of HA: YPYDVPDYA at the N terminus (Hishinuma et al. 2016) were cultured on glass coverslips in sixwell plates and treated without (control) or with 10 lM ionomycin or 0.1 mM histamine at 37°C for 30 min in normal HEPES buffer. These cells were fixed with phosphate-buffered saline containing 3% paraformaldehyde for 10 min and permeabilized with phosphate-buffered saline containing 0.1% Triton-X-100 and 0.1% bovine serum albumin for 10 min. Cells were then labeled with primary antibodies against HA at 4°C overnight to detect histamine H 1 receptors and then labeled with Alexa-Fluor-488-conjugated secondary antibodies at 37°C for 30 min. Confocal immunofluorescence microscopy was performed using a laser scanning microscope (LSM710; Carl Zeiss, Jena, Germany).
Measurement of histamine-induced accumulation of [ 3 H]inositol phosphates
Histamine-induced accumulation of [ 3 H]inositol phosphates was measured as described previously (Hishinuma et al. 2016) . Briefly, cells were cultured on 10-cm dishes and incubated with 0.12 lM myo-[ 3 H]inositol (2.5 lCi/mL) for 24 h at 37°C. Cells were dissociated and treated without (control) or with 10 lM ionomycin at 37°C for 30 min in normal HEPES buffer before stimulation without (basal) or with the indicated concentrations of histamine for 30 min at 37°C in Krebs-Henseleit buffer (in mM: NaCl 116, KCl 4.7, MgSO 4 1.2, CaCl 2 2.5, KH 2 PO 4 1.2, NaHCO 3 25 and D-glucose 11; pH 7.4) containing 30 mM LiCl. [ 3 H]inositol phosphates accumulated within the cells were collected with an AG 1-X8 anion-exchange column and the radioactivity was determined by scintillation counting. All determinations were performed in quadruplicate.
Measurement of changes in intracellular Ca
2+ concentrations with an intracellular Ca 2+ indicator, fura 2-AM Changes in intracellular Ca 2+ concentrations were measured as described previously (Hishinuma and Ogura 2000) . Briefly, cells were grown on 35-mm glass-bottom dishes and incubated with 1 lM fura 2-AM and 0.02% Cremophor â EL for 60 min in the dark at room temperature (approximately 25°C). The fura 2-AMloaded cells were stimulated with 0.1 mM histamine or 10 lM ionomycin in normal HEPES buffer before treatment with 10 mM EGTA. Fluorescence of the cells at an emission wavelength of 500 nm after excitation at 340 and 380 nm (F 340 and F 380 , respectively) and the ratio (F 340 /F 380 ) was monitored with a fluorescence microscope (IX71; Olympus, Tokyo, Japan) and a Ca 2+ imaging software (MetaMorph; Molecular Devices, Tokyo, Japan).
Data analysis
Results are presented as the mean AE SEM. 
where B is the amount bound, B max is the maximum amount bound, C is the concentration of [ 
where E max is the maximal B max value, E min is the minimal B max value, EC 50 is the effective concentration of Ca 2+ to induce a halfmaximal percentage reduction in B max values, C is the concentration of Ca 2+ , and n is the slope factor.
Concentration-response curves for the histamine-induced accumulation of [ 3 H]inositol phosphates were fit to a Hill equation (KaleidaGraph):
where Resp max is the maximal response of the histamine-induced accumulation of [ 3 H]inositol phosphates, C is the concentration of histamine, n is the Hill coefficient, and EC 50 is the effective concentration of histamine to induce a half-maximal response. et al. 1996) , or by the presence of 1.5 lM filipin and 54 lM nystatin (c and d), inhibitors of caveolae/lipid raft-dependent endocytosis (Orlandi and Fishman 1998; Ushio-Fukai et al. 2001) . These results suggest that the ionomycin-induced down-regulation of H 1 receptors occurred without receptor endocytosis via clathrin and caveolae/lipid rafts.
Results
Ionomycin-induced increase in intracellular Ca
Slowiejko
Involvement of lysosomes and proteasomes in the ionomycin-induced loss of [ 3 H]mepyramine-binding sites
We investigated the involvement of lysosomes and proteasomes in the ionomycin-induced loss of [ 3 H]mepyramine-binding sites in intact CHO cells (Fig. 4) . Ionomycininduced reductions in the mepyramine (a, c and e)-and pirdonium (b, d and f)-sensitive binding of [ 3 H]mepyramine were affected by neither lysosomal protease inhibitors (a-d; 0.1 mM E-64, 0.1 mM leupeptin, 0.1 mM chloroquine, and 10 mM NH 4 Cl) (Aoyagi et al. 1969; de Duve et al. 1974) nor proteasome inhibitors (e and f; 10 lM lactacystin and 50 lM MG-132) (Fenteany et al. 1995; Tsubuki et al. 1996; Kisselev and Goldberg 2001) . These results suggest that the ionomycin-induced down-regulation of H 1 receptors was not caused by receptor degradation via lysosomes and proteasomes. (Tanaka 1988; Agullo and Garcia 1997) or protein kinase C inhibitors (e and f; 3 lM chelerythrine and 100 nM GF109203X) (Herbert et al. 1990; Martiny-Baron et al. 1993) . These results suggest that the ionomycininduced down-regulation of H 1 receptors was caused by Ca 2+ -dependent, but calmodulin/protein kinase C-independent mechanisms.
Involvement of
Involvement of calpain and ubiquitin-activating enzyme (E1) in the ionomycin-induced loss of [ 3 H]mepyraminebinding sites
We then evaluated the involvement of calpain, a calciumdependent and non-lysosomal cysteine protease, and a ubiquitin-activating enzyme (E1), which catalyzes the first step of the ubiquitination of proteins, in the ionomycin- (Fig. 7a) , since intracellular Ca 2+ concentrations are thought to become equivalent to extracellular Ca 2+ concentrations via the action of ionomycin (Sato et al. 1988) . It was estimated that B max values for the mepyramine-sensitive binding of [ 3 H]mepyramine were maximally reduced to 7.6 AE 13.7% by Ca 2+ and that EC 50 values for Ca 2+ to induce a half-maximal percentage reduction in B max values were 0.20 AE 0.12 mM. Significant reduction in the mepyramine-sensitive binding of [ 3 H] mepyramine was induced by relatively high concentrations of Ca 2+ (0.1 mM or more), which were thought to be 100 times higher than intracellular Ca 2+ concentrations increased by 0.1 mM histamine (Hishinuma and Ogura 2000) . These results suggest that the ionomycin-induced loss of [ 3 H]mepyraminebinding sites might be caused by markedly high concentrations of intracellular Ca 2+ . The ionomycin-induced reduction in B max values for the mepyramine-sensitive binding of [ 3 H]mepyramine did not significantly recover up to 4 h after removal of extracellular Ca 2+ with 10 mM EGTA in CHO cells and the percentage of cell viability estimated by trypan blue staining was 96.0 AE 1.9% for control cells and 2.1 AE 1.0% for cells treated with 10 lM ionomycin for 30 min in normal HEPES buffer (n = 3). These results suggest that the ionomycininduced down-regulation of H 1 receptors might be an irreversible process accompanied by a loss of cell viability as a possible pathophysiological mechanism responsible for cytotoxic Ca 2+ . To evaluate whether intracellular Ca 2+ might directly reduce the [ 3 H]mepyramine binding to H 1 receptors, membranes were prepared from ionomycin-non-treated CHO cells and the mepyramine-sensitive [ 3 H]mepyramine binding was measured in 25 mM HEPES buffer simply containing either 0.2 mM EGTA (control) or 1.8 mM CaCl 2 (Fig. 7b) Confocal immunofluorescence microscopy to detect the ionomycin-induced loss of cellular histamine H 1 receptors In order to clarify whether H 1 receptor molecules are lost after the ionomycin treatment, we used CHO cells expressing human histamine H 1 receptors tagged with HA at the N terminus (Hishinuma et al. 2016) , in which H 1 receptors were detected by an anti-HA antibody instead of [ 3 H]mepyramine (Fig. 8) . Confocal immunofluorescence microscopy showed that the anti-HA antibody, which was predominantly detected on the cell surface in ionomycin-non-treated control cells in normal HEPES buffer (a; control), was still detected in ionomycin-treated cells (b) in a similar manner to control cells. In contrast, the anti-HA antibody was predominantly detected in intracellular compartments in histamine-treated cells (c), which indicated histamine-induced internalization of H 1 receptors. Thus, cellular H 1 receptors appeared to normally exist in ionomycin-treated cells in a form detectable with the anti-HA antibody, but not with with the loss of the pirdonium-sensitive binding sites of [ 3 H] mepyramine, cell-surface H 1 receptors appeared to be lost by ionomycin. Since the agonist-induced internalization of H 1 receptors is generally considered to be a pre-requisite process for their subsequent down-regulation in lysosomes and/or proteasomes, we examined the involvement of receptor endocytosis in the ionomycin-induced down-regulation of H 1 receptors. We found that the loss of cell-surface H 1 receptors was not caused by receptor endocytosis via clathrin and caveolae/lipid rafts. Thus, the ionomycin-induced downregulation of H 1 receptors appeared to occur without the process of receptor endocytosis. Accordingly, lysosomes and proteasomes did not appear to be involved in the ionomycininduced down-regulation of H 1 receptors. A down-regulation pathway that does not require endocytosis is known to exist in the agonist-induced down-regulation of muscarinic M 2 receptors in CHO cells ) and ß 2 -adrenoceptors in murine fibroblast L cells and A431 human epidermoid carcinoma cells (Jockers et al. 1999) . However, these processes are in contrast to those for the agonistinduced down-regulation of H 1 receptors in CHO cells, which is considered to occur via proteasome/lysosomemediated degradation after clathrin-dependent receptor endocytosis (Hishinuma et al. 2010) . Confocal immunofluorescence microscopy indicated that cellular H 1 receptors existed even after the ionomycin treatment in a form detectable by the antibody against HA-tagged H 1 receptors, but not by [ 3 H]mepyramine, with no subcellular changes in receptor distribution. This was also in contrast to our previous findings showing that cell-surface H 1 receptors were delivered to the Golgi apparatus upon a stimulation with an agonist (Hishinuma et al. 2016) . Ionomycin-induced down-regulation of H 1 receptors involves Ca 2+ -dependent, but calmodulin/protein kinase C/ calpain-independent mechanisms The ionomycin-induced down-regulation of H 1 receptors was revealed to be regulated by Ca 2+ -dependent, but calmodulin/ protein kinase C-independent mechanisms, whereas the agonist-induced internalization and down-regulation of H 1 receptors were found to be regulated by Ca 2+ /calmodulin and protein kinase C (Hishinuma et al. 1998 (Hishinuma et al. , 2010 . The ionomycin-induced down-regulation of H 1 receptors might not be caused by the direct action of intracellular Ca 2+ to H 1 receptors, since the mepyramine-sensitive binding of [ 3 H] mepyramine was well retained in membrane preparations in the presence of Ca 2+ . Calpain, which is known to be involved in the ionomycin-induced down-regulation of androgen receptors (Libertini et al. 2007) , the inositol 1,4,5-trisphosphate receptor (Kopil et al. 2011) , the K-Cl co-transporter KCC2 (Puskarjov et al. 2012) , and epidermal growth factor receptor (Liao and Carpenter 2012) , did not appear to be involved in this Ca 2+ -dependent down-regulation of H 1 receptors. One possible mechanism involved may be conformational changes in receptor molecules via ubiquitination, by which [ 3 H]mepyramine, but not the anti-HA antibody, failed to bind to the receptors; however, the mechanisms by which ubiquitination processes are regulated by Ca 2+ remained to be elucidated. Nevertheless, this Ca 2+ -dependent and endocytosis-independent down-regulation of H 1 receptors may function as an alternative or additional regulatory mechanism for cellular homeostasis in response to a sustained increase in intracellular Ca 2+ concentrations.
Conclusions
This study provided the evidence that the binding capacity of ligands for GPCRs could be lost by a sustained increase in intracellular Ca 2+ concentrations with no apparent endocytosis and lysosomal/proteasomal degradation of receptors. These results provide a novel insight into how ligand sensitivity of receptors is regulated by intracellular Ca 2+ .
